Improved (4 Plus 2) Rituximab Protocol for Severe Cases of Mixed Cryoglobulinemia: A 6-Year Observational Study

Conclusion: In this open, prospective study, RTX appeared to be very effective and safe in the treatment of the most severe cases of MC.Am J Nephrol 2016;43:251-260
Source: American Journal of Nephrology - Category: Neurology Source Type: research